+1 to HPLC_Greg. Especially the point about "CardioMD perspective but I think this ov..." — I have seen the same in my own experience with UK NHS GLP-1 prescribing .

Want to share my personal experience related to UK NHS GLP-1 prescribing since I think it might help others in a similar situation.

I started my GLP-1 journey in October 2024 at 247 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.

Now, 18 months later: I am down 62 lbs, my labs have normalized, and I am off 2 of my 3 medications. The UK NHS GLP-1 aspect specifically was something that made a big difference in my journey.

This community helped me every step of the way.

Dr.BariatricHTX — that is really helpful context on UK NHS GLP-1 prescribing . Follow-up question: did you experience any side effects during this phase?

I am in a similar situation (about to start) and trying to set realistic expectations.

To answer LibrarianMeg's question specifically:

From a clinical standpoint, UK NHS GLP-1 prescribing is something I discuss with patients regularly.

The short answer: discuss this specific situation with your prescribing provider.

The longer answer involves weighing the risk-benefit ratio for your individual situation, which I am happy to elaborate on if helpful.

Saving this for reference. Quality thread.